Skip to main content

Advertisement

Table 2 Univariate and multivariate analyses of disease-free survival

From: Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma

Variables Univariate analysis Multivariate analysis
HR 95% CI p-value HR 95% CI p-value
Agea 0.98 0.95–1.01 0.140    
FIGO stage 2.02 1.36–3.00 < 0.001    
Tumor sizea 1.43 1.14–1.08 0.002 1.37 1.06–1.77 0.015
Pelvic lymph node 1.89 0.90–3.96 0.094    
Para-aortic lymph node 4.21 1.89–9.40 < 0.001 3.75 1.39–10.15 0.009
SCC antigena 1.01 1.00–1.01 0.122    
pSUVmaxa 1.04 0.99–1.08 0.086    
Nodal SUVmaxa 1.07 1.04–1.11 < 0.001 1.05 1.01–1.09 0.020
HPV negative 2.37 1.01–5.55 0.047 3.68 1.44–9.41 0.007
  1. aAge, Tumor size, SCC antigen, pSUVmax, nodal SUVmax were analyzed as continuous variables. Hazard ratio represents the increase in hazard for each variable
  2. HR hazard ratio, FIGO International Federation of Gynecology and Obstetrics, SCC squamous cell carcinoma, SUVmax maximum standardized uptake, pSUVmax SUVmax of primary tumor, nodal SUVmax SUVmax of the lymph node with the highest FDG uptake, HPV human papilloma virus